- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ApicHope Pharmaceutical Co Ltd (300723)
ApicHope Pharmaceutical Co Ltd stock price live, this page displays SZ 300723 stock exchange data. View the 300723 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ApicHope Pharmaceutical Co Ltd real time stock price chart below.
What Is the ApicHope Pharmaceutical Co Ltd Stock Price Today?
The ApicHope Pharmaceutical Co Ltd stock price today is 40.50.
What Is the Stock Symbol for ApicHope Pharmaceutical Co Ltd?
The stock symbol for ApicHope Pharmaceutical Co Ltd is "300723."
What Stock Exchange Does ApicHope Pharmaceutical Co Ltd Trade On?
ApicHope Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is ApicHope Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether ApicHope Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300723 quote. (ISIN: CNE1000035J7)
What Is the ApicHope Pharmaceutical Co Ltd Stock Price Today?
The ApicHope Pharmaceutical Co Ltd stock price today is 40.50.
What Is the Stock Symbol for ApicHope Pharmaceutical Co Ltd?
The stock symbol for ApicHope Pharmaceutical Co Ltd is "300723."
What Stock Exchange Does ApicHope Pharmaceutical Co Ltd Trade On?
ApicHope Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is ApicHope Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether ApicHope Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300723 quote. (ISIN: CNE1000035J7)
Shenzhen
Currency in CNY
40.50
-0.79(-1.91%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
39.61
44.80
52 wk Range
29.31
81.48
300723 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
39.6144.80
52 wk Range
29.3181.48
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300723 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
35.88
Downside
-11.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 35.88
(-11.41% Downside)
Earnings
Latest Release
Apr 23, 2026
EPS / Forecast
1.32 / --
Revenue / Forecast
385.47M / --
Compare 300723 to Peers and Sector
Metrics to compare | 300723 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300723PeersSector | |
|---|---|---|---|---|
P/E Ratio | 92.6x | −7.0x | −0.4x | |
PEG Ratio | 0.69 | 0.04 | 0.00 | |
Price/Book | 9.6x | 2.0x | 2.6x | |
Price / LTM Sales | 19.7x | 2.9x | 3.0x | |
Upside (Analyst Target) | −13.1% | 42.9% | 49.1% | |
Fair Value Upside | Unlock | −5.6% | 6.3% | Unlock |
ApicHope Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pharmaceutical drugs in China. The company offers pediatric medicines, such as fuganlin and yiqi jianpi oral liquids, carboxymestrine oral solutions, and xiao’er kechuanling oral liquid products; and clindamycin palmitate hydrochloride dispersible tablets, acetylkitasamycin for suspension, qinxiangqingjie oral liquids, epinastine hydrochloride granules, clindamycin palmitate hydrochloride granules, clindamyxin hydrochloride for injection, clindamycin phosphate injection, ambroxol hydrochloride drops, montelukast sodium oral granules, oseltamivir phosphate capsules, and levocetirizine dihydrochloride oral drops. It also provides chronic disease drugs, including aciclovir for injection, hepatocyte growth-promoting factor for injection, pentoxifylline injection, kangshen and niaoqingshu granules, shenbo lotion, compound monoammonium glycyrrhizinate s and lansoprazole for injection, omeprazole sodium for injection, and other products. In addition, the company offers compound elsholtzia liquid, yinhuang oral liquid, and xiongdan chuanbei oral liquid products; levofloxacin hydrochloride for injection, ketorolac trometamol injection, phloroglucinol injection, ibuprofen tablets, vidarabine monophosphate for injection, lexofloxacin tablets, tranexamic acid injection, ropivacaine hydrochloride injection, mecobalamin injection, linezolid for oral suspension, clindamyxin hydrochloride for injection, caspofungin acetate for injection, and tongxuan lifei tablets. Further, it engages in scientific research and technical services; wholesale and retail trade; information technology; and technology promotion and application services. The company was formerly known as ApicHope Pharmaceutical Co., Ltd and changed its name to ApicHope Pharmaceutical Group Co., Ltd. in December 2024. ApicHope Pharmaceutical Group Co., Ltd. was founded in 2002 and is headquartered in Guangzhou, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the ApicHope Pharmaceutical (300723) Stock Price Today?
The ApicHope Pharmaceutical stock price today is 40.50 CNY.
What Stock Exchange Does ApicHope Pharmaceutical Trade On?
ApicHope Pharmaceutical is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for ApicHope Pharmaceutical?
The stock symbol for ApicHope Pharmaceutical is "300723."
What Is the ApicHope Pharmaceutical Market Cap?
As of today, ApicHope Pharmaceutical market cap is 18.17B CNY.
What Is ApicHope Pharmaceutical's Earnings Per Share (TTM)?
The ApicHope Pharmaceutical EPS (TTM) is 0.44.
When Is the Next ApicHope Pharmaceutical Earnings Date?
ApicHope Pharmaceutical will release its next earnings report on Aug 27, 2026.
From a Technical Analysis Perspective, Is 300723 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has ApicHope Pharmaceutical Stock Split?
ApicHope Pharmaceutical has split 2 times.
How Many Employees Does ApicHope Pharmaceutical Have?
ApicHope Pharmaceutical has 1294 employees.
What is the current trading status of ApicHope Pharmaceutical (300723)?
As of Jul 06, 2026, ApicHope Pharmaceutical (300723) is trading at a price of 40.50 CNY, with a previous close of 41.29 CNY. The stock has fluctuated within a day range of 39.61 CNY to 44.80 CNY, while its 52-week range spans from 29.31 CNY to 81.48 CNY.
What Is ApicHope Pharmaceutical (300723) Price Target According to Analysts?
The average 12-month price target for ApicHope Pharmaceutical is 35.88 CNY, with a high estimate of 35.88 CNY and a low estimate of 35.88 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -11.41% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.